BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 17200425)

  • 21. Cost-effectiveness analysis of linezolid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus: complicated skin and skin structure infection using Bayesian methods for evidence synthesis.
    Bounthavong M; Zargarzadeh A; Hsu DI; Vanness DJ
    Value Health; 2011; 14(5):631-9. PubMed ID: 21839399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Community-associated methicillin-resistant Staphylococcus aureus: new bug, old drugs.
    Sabol KE; Echevarria KL; Lewis JS
    Ann Pharmacother; 2006 Jun; 40(6):1125-33. PubMed ID: 16735661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic.
    Szumowski JD; Cohen DE; Kanaya F; Mayer KH
    Antimicrob Agents Chemother; 2007 Feb; 51(2):423-8. PubMed ID: 17116664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus.
    Sharpe JN; Shively EH; Polk HC
    Am J Surg; 2005 Apr; 189(4):425-8. PubMed ID: 15820454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections.
    Adra M; Lawrence KR
    Ann Pharmacother; 2004 Feb; 38(2):338-41. PubMed ID: 14742775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trimethoprim-sulfamethoxazole plus topical antibiotics as therapy for acute otitis media with otorrhea caused by community-acquired methicillin-resistant Staphylococcus aureus in children.
    Al-Shawwa BA; Wegner D
    Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):782-4. PubMed ID: 16172354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergency management of pediatric skin and soft tissue infections in the community-associated methicillin-resistant Staphylococcus aureus era.
    Mistry RD; Weisz K; Scott HF; Alpern ER
    Acad Emerg Med; 2010 Feb; 17(2):187-93. PubMed ID: 20370748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection.
    Proctor RA
    Clin Infect Dis; 2008 Feb; 46(4):584-93. PubMed ID: 18197761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Community-acquired MRSA infections in North Carolina children: prevalence, antibiotic sensitivities, and risk factors.
    Shapiro A; Raman S; Johnson M; Piehl M
    N C Med J; 2009; 70(2):102-7. PubMed ID: 19489364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and management of Staphylococcus aureus infections of the skin and soft tissue.
    Roberts S; Chambers S
    Intern Med J; 2005 Dec; 35 Suppl 2():S97-105. PubMed ID: 16271065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned?
    Lewis JS; Jorgensen JH
    Clin Infect Dis; 2005 Jan; 40(2):280-5. PubMed ID: 15655748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus.
    Cenizal MJ; Skiest D; Luber S; Bedimo R; Davis P; Fox P; Delaney K; Hardy RD
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2628-30. PubMed ID: 17502411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community- and health care-associated methicillin-resistant Staphylococcus aureus: a comparison of molecular epidemiology and antimicrobial activities of various agents.
    Tsuji BT; Rybak MJ; Cheung CM; Amjad M; Kaatz GW
    Diagn Microbiol Infect Dis; 2007 May; 58(1):41-7. PubMed ID: 17300912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing incidence of methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: reconsideration of empiric antimicrobial therapy.
    Awad SS; Elhabash SI; Lee L; Farrow B; Berger DH
    Am J Surg; 2007 Nov; 194(5):606-10. PubMed ID: 17936421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.
    Mauldin PD; Salgado CD; Durkalski VL; Bosso JA
    Ann Pharmacother; 2008 Mar; 42(3):317-26. PubMed ID: 18285560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.
    McKinnon PS; Sorensen SV; Liu LZ; Itani KM
    Ann Pharmacother; 2006 Jun; 40(6):1017-23. PubMed ID: 16720705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of Staphylococcus aureus infections and the prevalence of infection caused by community-acquired methicillin-resistant Staphylococcus aureus in hospitalized patients at Siriraj Hospital.
    Mekviwattanawong S; Srifuengfung S; Chokepaibulkit K; Lohsiriwat D; Thamlikitkul V
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S106-17. PubMed ID: 17722301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic options for treating community-acquired MRSA.
    Powell JP; Wenzel RP
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):299-307. PubMed ID: 18588495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Community-acquired methicillin-resistant Staphylococcus aureus infections in children: multicenter trial].
    Paganini H; Della Latta MP; Muller Opet B; Ezcurra G; Uranga M; Aguirre C; Ensinck G; Kamiya de Macarrein M; Miranda MR; Ciriaci C; Hernández C; Casimir L; Rial MJ; Schenonne N; Ronchi E; Rodríguez Mdel C; Aprile F; De Ricco C; García Saito V; Vrátnica C; Pons L; Ernst A; Morinigo S; Toffoli M; Bosque C; Monzani V; Mónaco A; Pinheiro JL; López Mdel P; Maninno L; Sarkis C
    Arch Argent Pediatr; 2008 Oct; 106(5):397-403. PubMed ID: 19030638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clindamycin is unsuitable for the empirical treatment of infections due to pig-related methicillin-resistant Staphylococcus aureus (MRSA)].
    Renders NH; Janssen MH; Leenders AC
    Ned Tijdschr Geneeskd; 2007 Oct; 151(41):2277-80. PubMed ID: 17987897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.